The IJTLD (ISSN:1815-7920) provides a free-to-publish journal for authors (mainly in LMICs), who lack open access funding and conduct research on respiratory health.
The Journal primarily focuses on infectious diseases, including TB and non-tuberculous mycobacterial (NTM) infections, alongside the role of risk factors and comorbidities, with the aim of improving clinical care, policy and practise.
Individuals and Institutes can subscribe to the IJTLD online, simply e-mail us at subscription@theunion.org
Information for Authors
Abstract and indexing services include: Medline, PubMed, Scopus, EMBASE, Web of Science, SciSearch®, Medical Documentation Service®, ISI Alerting Services, Current Contents®/Clinical Medicine, the Science Citation Index®, the SIIC databases, CLOCKSS and LOCKSS.
Other Information
- Frequency: monthly
- Permission requests: contact IJTLD Editorial Office.
There are no fees for articles that meet our recommended page lengths, but there are fees for additional pages or supplementary data - see Journal Publication Charges
IJTLD Open as an open access alternative to the IJTLD. The Journal focuses on infectious diseases, including TB and non-tuberculous mycobacteria (NTM), alongside the role of risk factors and comorbidities.
IJTLD Open includes a broader range of article types than the traditional IJTLD, including: Editorials, Meeting reports; Original Articles (including methodology papers, qualitative research and operational research), State of the Art Reviews; Guidelines/Consensus documents; Systematic Reviews and Meta-Analysis; Viewpoints; Minireviews, Letters; Study Protocols; Case reports; Case series and Correspondence.
We have launched IJTLD CRD for open access coverage of chronic respiratory disease in low- and middle-income countries.
IJTLD CRD coverage includes: post TB lung disease (PTLD), asthma, COPD, impact of air pollution, lung damage in smokers, interstitial lung disease, bronchiectasis, long COVID, sleep apnoea, occupational lung disease and interventional pulmonology.
We are particularly keen to promote research on early diagnosis and treatments – including the latest therapeutic advances that have relevance across a wide range of respiratory conditions.
The latest peer-reviewed articles on TB and HIV; respiratory diseases such as asthma and COPD; and the hazards of tobacco and air pollution. Recent coverage has expended to include COVID-19 and the interplay between TB-COVID-19 and other co-morbidities.
Individuals and institutes can subscribe to the IJTLD online – see our Subscription information or e-mail us at subscription@theunion.org for details.
IJTLD Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD and publishing them in full on our website, prior to their publication in the Journal. Read fast-track articles:
How TB and COVID-19 compare: an opportunity to integrate both control programmes
Letter to the editors which highlights similarities and differences between TB and COVID-19 – and proposes that control programmes unite to address both conditions.
COVID-19: ensuring continuity of TB services in the private sector
Pakistan has the fifth largest global burden of TB, and in response to COVID-19 a lockdown was imposed on 26 February. TB services were severely disrupted. This threatened to undermine recent gains in private-sector engagement and TB elimination efforts.
Responding to COVID-19: adjusting TB services in a low-burden setting
A letter to the editors in which the Victorian Tuberculosis Program describes how the social and programmatic changes to TB services brought on by COVID-19 have been experienced in practice.
COVID-19 in Africa: community and digital technologies for tuberculosis management
This letter explores the concerns about the negative impact that COVID-19 will have on the fight against tuberculosis in Africa
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic
This letter looks at the implications and potential consequences of delayed or missed diagnoses for TB, which may increase TB-related hospitalisations and death.
COVID-19 and tuberculosis—threats and opportunities
In an editorial to the IJTLD, the authors state how we must overcome the challenges that COVID-19 presents and use the opportunities it affords us to achieve a paradigm shift in TB treatment and care
Other versions of the journal
The IJTLD has been published in several languages, and publishes the Union World Conference abstract book each year.
Contact
For all IJTLD enquiries, please contact the IJTLD Editorial Office.